Abstract
The reaction of N,N’-(1,4-phenylene)bis(2-cyano-3-(dimethylamino)acrylamide) (2) with resorcinol, α-naphthol, β-naphthol, dimedone and indandione in acetic acid afforded bischromene derivatives 4, 6, 8, 12 and 14, respectively. Similarly, treatment of 2 with barbituric acid, thiobarbituric acid and 3-methyl-1-phenyl-1H-pyrazol-5(4H)-one to give pyrano[2,3-b]pyrimidine 16, 18, and pyrano[2,3-c]pyrazole 20 derivatives. Moreover, 2 react with thiocyanoacetamide to afford 2-pyridone derivative 24. The newly synthesized compounds were evaluated as antitumor activities. The results showed that four compounds, namely 4, 10, 18 and 24, displayed promising in vitro antitumor activity in the four cell lines assay.
Similar content being viewed by others
References
M.P. Perrino, R.O. Villar-Guerra, M.C. Sanudo, L.A. Calvo, A. Gonzalez-Ortega, Tetrahedron 66, 2815–2822 (2010)
M.A.A. Radwan, E.A. Ragab, M.R. Shaaban, A.O.H. El-Nezhaw, Arkivoc vii, 281–291 (2009)
N. Oukli, S. Comesse, N. Chafi, H. Oulyadi, A. Daich, Tetrahedron Lett. 50, 1459–1462 (2009)
M.V. Pilipecz, T.R. Varga, Z. Mucsi, P. Scheiber, P. Nemes, Tetrahedron 64, 5545–5550 (2008)
F. Al-Qalaf, M.M. Abdelkhalik, A. El-Enezi, J.R. Al-Ajimi, Heterocycles 75, 145–156 (2008)
A.M. Salaheldin, M.K. Alphy, J. Heterocycl. Chem 45, 307–310 (2008)
G.R. Geen, J.M. Evans, A.K. Vong, In comprehensive heterocyclic chemistry II (Pergamon Press:Oxford, 1996), vol. 5, pp. 469–500
F. Po_zgan, F. Kranjc, V. Kepe, S. Polanc, M. Ko_cevar, Arkivoc viii, 97–111 (2007)
B. Stanovnik, Svete. J. Chem Rev 104, 2433–2480 (2004)
M. Ghandi, E. Babazadeh, J. Iran. Chem. Soc (2014). doi:10.1007/s13738-014-0494-7
H. Mehrabi, H. Abusaidi, J. Iran. Chem. Soc 7, 890–894 (2010)
A.A. Emmanuel-Giota, K.C. Fylaktakidou, D.J. Hadjipavlou-Litina, K.E. Litinas, D.N. Nicolaides, J. Heterocycl. Chem 38, 717–722 (2001)
I. Manolov, N.D. Danchev, Eur. J. Med. Chem. 30, 531–535 (1995)
M.A. Al-Haiza, M.S. Mostafa, M.Y. El-Kady, Molecules 8, 275–286 (2003)
B. Kalluraya, P. Vishwanatha, A.M. Isloor, G. Rai, M. Kotian, Boll. Chim. Farm. 139, 263–266 (2000)
O.A. Abd-Allah, Il Farmaco 55, 641–649 (2000)
Z.M. Nofal, M.I. El-Zahar, S.S. Abd, El-Karim. Molecules 5, 99–113 (2000)
L. Raev, E. Voinov, I. Ivanov, D. Popov, Pharmazie 45, 696 (1990)
M. Torres, S. Gil, M. Parra, Curr. Org. Chem 9, 1757–1779 (2005)
J.H. Rigby, M.M. Dejmek, R. Selke, T. Tanaka, T Azuma, Synlett 1 (2000)
A.A. Fadda, H.M. Refat, Synth. Commun 30, 341–350 (2000)
A.A. Fadda, H.M. Refat, M.E.A. Zaki, Molecules 5, 701–709 (2000)
A.A. Fadda, M.M. Mukhtar, H.M. Refat, Am. J. Org. Chem 2, 32–40 (2012). doi:10.5923/j.ajoc.20120202.06
H.M. Refat, A.A. Fadda, Eur. J. Med. Chem 70, 419–426 (2013)
A. Fadda, H.M. Refat, Sh Kamal, Eur. J. Chem 5, 296–304 (2014)
A.A. Fadda, M.A. Berghot, F.A. Amer, D.S. Badawy, N.M. Bayoumy, Arch. Pharm 345, 378–385 (2012)
F. Denizot, R. Lang, J. Immunol. Methods 22, 271–277 (1986)
M.I. Thabrew, R.D. Hughes, I.G. McFarlane, J. Pharm. Pharmacol 49, 1132–1135 (1997)
Acknowledgments
The authors are thankful to Department of Pharmacology, Faculty of Pharmacy, Mansoura University, Egypt, for performing the antitumor evaluation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Refat, H.M., Fadda, A.A. & Kamal, S. Synthesis and antitumor evaluation of some new biscarboxamidocoumarin and chromene derivatives. J IRAN CHEM SOC 12, 845–854 (2015). https://doi.org/10.1007/s13738-014-0547-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13738-014-0547-y